Two unique cases of chronic calcified subdural hematomas are reported in children as a long-term complication of a ventriculoperitoneal shunt. Both the patients had undergone shunt procedures in infancy for congenital hydrocephalus. In one patient, the cause of the hydrocephalus was aqueduct stenosis, while in the second patient, a lumbar meningomyelocele was associated with hydrocephalus. In both these patients, a ventriculoperitoneal shunt was done in infancy. In one of them, following the shunt surgery, a bilateral subdural collection was noticed which required burr hole evacuation. Both the patients remained asymptomatic for 9 years, when they presented to our center with acute raised intracranial pressure and contralateral hemiparesis. Both the patients had a relatively short history and had altered sensorium at admission. Surprisingly, in both the patients, the CT scan showed significant mass effect producing calcified subdural hematomas. The shunt systems were found to be working well at surgery. Craniotomy and excision of the calcified subdural hematomas was undertaken. Postoperatively, the patients showed satisfactory recovery, and at discharge the patients were doing well. At the follow-up at the outpatient clinic, the patients were asymptomatic.

1.
Boyd DA, Merrel JP: Calcified subdural hematoma. J Nerv Ment Dis 1943;98:609–617.
2.
Debois V, Lombaert A: Calcified subdural hematoma. Surg Neurol 1980;14:455–458.
3.
McLaurin RL, McLaurin KS: Calcified subdural hematoma in childhood. J Neurosurg 1966;24:648–655.
4.
Matsumoto M, Nojiri K: Asymptomatic calcified chronic subdural hematoma in the elderly. Neurol Med Chir (Tokyo) 1984;24:505–506.
5.
Granata F, Graziussi G, De Carlo C, Avella F, Fucci G: Calcified subdural hematoma, a case report. Acta Neurol (Napoli) 1977;32:340–341.
6.
Turgut M, Palaoglu S, Saglam S: Huge ossified crust like subdural hematoma covering the hemisphere and causing acute signs of increased intracranial pressure. Childs Nerv Syst 1997;13:415–417.
7.
Kao HI, Hsueh K, Hsueh T: Huge calcified chronic subdural hematoma in the elderly – Report of a case. Chih 1997;13:272–276.
8.
Harwood-Nash DC: Craniocerebral trauma in children. Curr Prob Radiol 1973;3:1.
9.
Afa D: Ossification of subdural hematoma. Report of two cases. J Neurosurg 1961;18:393–397.
10.
Iplikcioglu AC, Akkas O, Sungur R: Ossified chronic subdural hematoma, case report. J Trauma 1991;31:272–275.
11.
Kulali A, Cihanser E, Filiz O, Simsey O: Giant calcified subdural empyema. Surg Neurol 1994;42:442–447.
12.
Yamada K, Ohta T, Takatsuka H, Yamaguchi K: High field magnetic resonance image of a huge calcified chronic subdural hematoma, so called ‘armored brain’. Acta Neurochir (Wien) 1992;114:151–153.
13.
Ludwig B, Nix W, Lanksch W: Computed tomography of the ‘armored brain’. Neuroradiol 1983;25:39–43.
14.
Ide M, Jimbo M, Yamamoto M, Umebara Y, Hagiwara S: Asymptomatic calcified chronic subdural hematoma – A report of 3 cases. Neurol Med Chir (Tokyo) 1993;33:559–563.
15.
Waga S, Sakakura M, Fujimoto K: Calcified subdural hematoma in the elderly. Surg Neurol 1997;11:51–53.
16.
Alferdo P, Fernandez E, Colosimo C, Liverana L, Pallini R, Tamburrini G: Hydrocephalus and macrocranial, surgical or non surgical treatment of the post shunt subdural hematoma. Surg Neurol 1993;45:376–382.
17.
Barmeir EP, Stern D, Havel S, Holtzman M, Krije TJ: Calcified subdural hematoma associated with arrested hydrocephalus – Late sequelae of shunt surgery in infancy. Eur J Radiol 1985;5:186–189.
18.
Illingworth RD: Sub-dural hematoma after treatment of chronic hydrocephalus by ventriculo-caval shunt. J Neurol Neurosurg Psychiatry 1970;33:95–99.
19.
Tvete S, Larsen JL: Intracranial calcification due to the chronic subdural hematoma in children with ventriculoatrial shunt. Report of two cases. ROFO Fortschr Geb Röntgenstr Nuklearmed 1978;129:506–507.
20.
Samuelsan S, Long DM, Chou SN: Subdural hematoma as a complication of shunting procedures for normal pressure hydrocephalus. J Neurosurg 1972;37:548–551.
21.
McKay RJ, Morisette RA, Ingratom FD, Matson DD: Calcification of the subdural fluid complicating meningitis due to Haemophilus influenzae (Type B). N Engl J Med 1950;242:20–21.
22.
Smith ES: Purulent meningitis in infants and children – A review of 409 cases. J Pediatr 1954;45:425–436.
23.
Goodman JM, Mealy J Jr: Post meningitic subdural effusion – The syndrome and its management. J Neurosurg 1969;30:658–663.
24.
Harwood-Nash DC, Fitz CR: Neuroradiology in Infants and Children. St Louis, Mosby, 1976.
25.
Niwa J, Nakamura T, Fujishige M, Hashi K: Removal of a large asymptomatic calcified subdural hematoma. Surg Neurol 1988;30:135–139.
26.
Spadaro A, Rotondo M, Di Celmo D, Simpatico S, Parlato C, Zotta DC, Albanese V: Bilateral calcified chronic subdural hematoma – Further pathologic and clinical considerations on the so called ‘armored brain’. J Neurosurg Sci 1987;31:49–52.
27.
Friede RL: Incidence and distribution of neo membranes of the dura mater. J Neurol Neurosurg Psychiatry 1971;34:439–446.
28.
Ludwig B, Nix W, Lanksch W: Computertomographie des ‘Panzerhirns’, 17. Jahrestagung der Deutschen Gesellschaft für Neuroradiologie, Tübingen, 1981;8:10.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.